ASAleksandra Sosińska

Aleksandra Sosińska

*This is an algorithmically generated author record based on publicly available information.

Aleksandra Sosińska has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    RARE VASCULAR DISEASES OF THE FEMALE REPRODUCTIVE TRACT: A LITERATURE REVIEW ON THE ETIOLOGY, DIAGNOSIS, AND TREATMENT OF UTERINE ARTERIOVENOUS MALFORMATIONS AND VULVAR ANEURYSMS

    by Justyna Rajczyk, Tomasz Rajczyk, Marcel Bobiński, Aleksandra Sosińska, Zuzanna Wieczorek, Adam Szymczak, Monika Wiczuk-Wiczewska, Justyna Bartol, Wiktoria Skowron, Kamil Kania

    Vascular disorders of the female reproductive tract, including uterine arteriovenous malformations (AVMs) and aneurysms or pseudoaneurysms of the uterine and pudendal arteries, represent extremely rare but potentially life-threatening conditions in gynecology. Due to their low incidence and nonspecific clinical presentation, these entities pose significant diagnostic and therapeutic challenges. Although uncommon, they may result in severe hemorrhage, particularly in the postpartum period or following intrauterine procedures. The aim of this narrative review is to summarize current evidence regarding the etiology, clinical manifestations, diagnostic imaging modalities, and treatment strategies for rare vascular abnormalities of the female reproductive system. A literature search was conducted using PubMed, Scopus, and Web of Science databases, including articles published between 2000 and 2025. Available data indicate that color Doppler ultrasonography is the primary diagnostic tool, while magnetic resonance imaging and angiography play a crucial role in confirmation and treatment planning. Selective endovascular embolization has emerged as the gold-standard therapy, providing high efficacy in hemorrhage control while preserving uterine integrity and reproductive potential in most patients. Despite favorable outcomes, standardized diagnostic and therapeutic algorithms are lacking. Further multicenter studies and case registries are required to optimize management strategies for these rare but clinically significant conditions.

  • Open Access

    SENOLYTICS – A DISCOVERY THAT COULD TRANSFORM THE COURSE OF AGING AND CHRONIC DISEASES

    by Kamil Kania, Marcel Bobiński, Zuzanna Wieczorek, Wiktoria Skowron, Justyna Bartol, Aleksandra Sosińska, Justyna Rajczyk, Monika Wiczuk–Wiczewska, Adam Szymczak, Tomasz Lepich

    Senescent cells play a pivotal role in the progression of age-related diseases by promoting chronic inflammation and disrupting tissue function through the secretion of senescence-associated secretory phenotype (SASP) factors. Senolytics, a novel class of therapeutic agents, enable the selective elimination of these cells or the attenuation of their deleterious effects, offering a potential avenue to enhance healthspan. Preclinical studies and early clinical trials indicate that senolytics can improve cardiovascular function, metabolism, and physical performance, while demonstrating an acceptable safety profile. This review presents the mechanisms of action of senolytics, the current state of research, and their potential applications in metabolic, neurodegenerative, and cardiovascular diseases.

  • Open Access

    ASCITES IN GASTROINTESTINAL CANCERS: A REVIEW OF SYMPTOMATIC TREATMENT METHODS AND THEIR EFFECTIVENESS

    by Wiktoria Skowron, Mateusz Kalita, Kamil Kania, Aleksandra Sosińska

    Introduction: Malignant Ascites (MA) is a serious complication of gastrointestinal cancers that significantly reduces quality of life and is associated with a poor prognosis. Its pathophysiology involves several mechanisms, including increased vascular permeability, venous compression, and lymphatic vessel infiltration. Material and methods: A literature review was conducted using the PubMed database, covering the years 2017–2025. Search phrases such as “malignant ascites” and “symptomatic treatment of ascites” were used. The review included clinical and review studies focusing on patients with MA associated with gastrointestinal cancers. Studies on ascites of other etiologies and preclinical research were excluded. Results: The most commonly used symptomatic treatment methods include paracentesis, diuretic therapy, peritoneovenous shunts, indwelling catheters, and intraperitoneal chemotherapy. Each method has its own advantages and limitations. Modern techniques such as HIPEC, immunotherapy, and photothermal therapy show promising results in preliminary studies. Conclusion: Malignant ascites requires an individualized therapeutic approach. It is essential to combine treatment efficacy with improvements in patients’ quality of life. Further research is needed to develop optimal strategies for symptomatic management.